Table 1 Socio-demographic profile of patients undergoing hyperacute stroke treatment
Treatment group, n (%) | ||||
|---|---|---|---|---|
Parameters | IVT | MT | IVT + MT | Overall |
Total | 48 | 11 | 16 | 75 |
Age | 57.8 ± 12.4 | 63.7 ± 13.3 | 68.0 ± 13.1 | 60.8 ± 13.2 |
Gender | ||||
Male | 38 (79.2) | 4 (36.4) | 10 (62.5) | 52 (69.3) |
Female | 10 (20.8) | 7 (63.6) | 6 (37.5) | 23 (30.7) |
Co-morbidities | ||||
Diabetes | 31 (24.6) | 3 (11.1) | 7 (19.4) | 41 (21.7) |
Hypertension | 32 (25.4) | 9 (33.3) | 10 (27.8) | 51 (26.9) |
Dyslipidemia | 26 (20.6) | 5 (18.5) | 8 (22.2) | 39 (20.6) |
Smoking | 13 (10.3) | 3 (11.1) | 2 (5.6) | 18 (9.5) |
Atrial fibrillation | 5 (3.9) | 1 (3.7) | 6 (16.7) | 12 (6.3) |
CKD | 3 (2.4) | 1 (3.7) | 1 (2.8) | 5 (2.6) |
IHD | 12 (9.5) | 3 (11.1) | 1 (2.8) | 16 (8.5) |
Previous stroke/TIA | 4 (3.2) | 2 (7.4) | 1 (2.8) | 7 (3.7) |
OXFORD classification | ||||
TACI | 12 (25.0) | 9 (81.8) | 13 (81.3) | 34 (45.3) |
PACI | 15 (31.3) | 1 (9.1) | 2 (12.5) | 18 (24.0) |
LACI | 18 (37.5) | 0 (0) | 0 (0) | 18 (24.0) |
POCI | 3 (6.3) | 1 (9.1) | 1 (6.7) | 5 (6.7) |